Claro Advisors LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Claro Advisors LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$18,200
-64.1%
10,0000.0%0.01%
-70.6%
Q4 2022$50,700
+37.0%
10,0000.0%0.02%
+13.3%
Q3 2022$37,0000.0%10,0000.0%0.02%0.0%
Q2 2022$37,000
-39.3%
10,0000.0%0.02%
-31.8%
Q1 2022$61,0000.0%10,0000.0%0.02%0.0%
Q4 2021$61,000
-37.1%
10,0000.0%0.02%
-46.3%
Q3 2021$97,000
-32.2%
10,0000.0%0.04%
-35.9%
Q2 2021$143,00010,0000.06%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders